1. Home
  2. SPRC vs LCFY Comparison

SPRC vs LCFY Comparison

Compare SPRC & LCFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRC
  • LCFY
  • Stock Information
  • Founded
  • SPRC 2004
  • LCFY 2009
  • Country
  • SPRC Israel
  • LCFY Australia
  • Employees
  • SPRC N/A
  • LCFY N/A
  • Industry
  • SPRC Biotechnology: Pharmaceutical Preparations
  • LCFY
  • Sector
  • SPRC Health Care
  • LCFY
  • Exchange
  • SPRC Nasdaq
  • LCFY Nasdaq
  • Market Cap
  • SPRC 3.4M
  • LCFY 3.7M
  • IPO Year
  • SPRC N/A
  • LCFY 2022
  • Fundamental
  • Price
  • SPRC $0.30
  • LCFY $6.30
  • Analyst Decision
  • SPRC
  • LCFY
  • Analyst Count
  • SPRC 0
  • LCFY 0
  • Target Price
  • SPRC N/A
  • LCFY N/A
  • AVG Volume (30 Days)
  • SPRC 195.0K
  • LCFY 4.9M
  • Earning Date
  • SPRC 02-15-2025
  • LCFY 07-07-2025
  • Dividend Yield
  • SPRC N/A
  • LCFY N/A
  • EPS Growth
  • SPRC N/A
  • LCFY N/A
  • EPS
  • SPRC N/A
  • LCFY N/A
  • Revenue
  • SPRC $1,306,000.00
  • LCFY $2,668,385.00
  • Revenue This Year
  • SPRC N/A
  • LCFY N/A
  • Revenue Next Year
  • SPRC N/A
  • LCFY N/A
  • P/E Ratio
  • SPRC N/A
  • LCFY N/A
  • Revenue Growth
  • SPRC N/A
  • LCFY N/A
  • 52 Week Low
  • SPRC $0.20
  • LCFY $2.28
  • 52 Week High
  • SPRC $1.79
  • LCFY $13.98
  • Technical
  • Relative Strength Index (RSI)
  • SPRC 49.11
  • LCFY 63.49
  • Support Level
  • SPRC $0.29
  • LCFY $2.51
  • Resistance Level
  • SPRC $0.34
  • LCFY $13.98
  • Average True Range (ATR)
  • SPRC 0.02
  • LCFY 0.91
  • MACD
  • SPRC -0.00
  • LCFY 0.42
  • Stochastic Oscillator
  • SPRC 33.33
  • LCFY 33.04

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

About LCFY Locafy Limited

Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.

Share on Social Networks: